Author:
Mera Robertino M,Bravo Luis E,Camargo M Constanza,Bravo Juan C,Delgado Alberto G,Romero-Gallo Judith,Yepez Maria C,Realpe José L,Schneider Barbara G,Morgan Douglas R,Peek Richard M,Correa Pelayo,Wilson Keith T,Piazuelo M Blanca
Abstract
ObjectiveTo evaluate the long-term effect of cumulative time exposed to Helicobacter pylori infection on the progression of gastric lesions.Design795 adults with precancerous gastric lesions were randomised to receive anti-H. pylori treatment at baseline. Gastric biopsies were obtained at baseline and at 3, 6, 12 and 16 years. A total of 456 individuals attended the 16-year visit. Cumulative time of H. pylori exposure was calculated as the number of years infected during follow-up. Multivariable logistic regression models were used to estimate the risk of progression to a more advanced diagnosis (versus no change/regression) as well as gastric cancer risk by intestinal metaplasia (IM) subtype. For a more detailed analysis of progression, we also used a histopathology score assessing both severity and extension of the gastric lesions (range 1–6). The score difference between baseline and 16 years was modelled by generalised linear models.ResultsIndividuals who were continuously infected with H. pylori for 16 years had a higher probability of progression to a more advanced diagnosis than those who cleared the infection and remained negative after baseline (p=0.001). Incomplete-type IM was associated with higher risk of progression to cancer than complete-type (OR, 11.3; 95% CI 1.4 to 91.4). The average histopathology score increased by 0.20 units/year (95% CI 0.12 to 0.28) among individuals continuously infected with H. pylori. The effect of cumulative time of infection on progression in the histopathology score was significantly higher for individuals with atrophy (without IM) than for individuals with IM (p<0.001).ConclusionsLong-term exposure to H. pylori infection was associated with progression of precancerous lesions. Individuals infected with H. pylori with these lesions may benefit from eradication, particularly those with atrophic gastritis without IM. Incomplete-type IM may be a useful marker for the identification of individuals at higher risk for cancer.
Funder
Office of Medical Research, Department of Veterans Affairs, USA
National Cancer Institute
Pasto Cancer Registry, Centro de Estudios en Salud, Universidad de Nariño
Intramural Research Program, U.S. National Institutes of Health, National Cancer Institute
Reference40 articles.
1. IARC working group on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori;IARC Monogr Eval Carcinog Risks Hum,1994
2. Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention;Correa;Cancer Res,1992
3. A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY
4. Gastric precancerous process in a high risk population: cohort follow-up;Correa;Cancer Res,1990
5. Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献